"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
(Generic versions may still be available.)
Atromid-S Side Effects Center
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Atromid-S in Detail - Patient Information: Side Effects
If you experience any of the following serious side effects, stop taking clofibrate and seek emergency medical attention:
- an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
- chest pain or an irregular heart beat;
- severe stomach pain with nausea and vomiting;
- fever and chills, a sore throat, or a flu-like feeling;
- blood in your urine or a decrease in urination;
- swelling of your ankles or legs;
- muscle cramps, muscle weakness, muscle aches, or muscle pain;
- joint pain; or
- sudden weight gain.
Other, less serious side effects may be more likely to occur. Continue to take clofibrate and talk to your doctor if you experience
- bloating or flatulence;
- nausea, vomiting, or diarrhea;
- dizziness or drowsiness; or
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Read the entire detailed patient monograph for Atromid-S (Clofibrate) »
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Atromid-S FDA Prescribing Information: Side Effects
The most common is nausea. Less frequently encountered gastrointestinal reactions are vomiting, loose stools, dyspepsia, flatulence, and abdominal distress. Reactions reported less often than gastrointestinal ones are headache, dizziness, and fatigue; muscle cramping, aching, and weakness; skin rash, urticaria, and pruritus; dry brittle hair, and alopecia.
The following reported adverse reactions are listed alphabetically by systems:
Increased or decreased angina.
Both swelling and phlebitis at site of xanthomas.
Allergic reactions including urticaria.
Dry skin and dry, brittle hair.
Toxic epidermal necrolysis.
Gastrointestinal upset (bloating, flatulence, abdominal distress).
Hepatomegaly (not associated with hepatotoxicity).
Stomatitis and gastritis.
Potentiation of anticoagulant effect.
Myalgia (muscle cramping, aching, weakness).
Rhabdomyolysis in the setting of preexisting renal insufficiency.
Fatigue, weakness, drowsiness.
Increased creatine phosphokinase.
Reported adverse reactions whose direct relationship with the drug has not been established: peptic ulcer, gastrointestinal hemorrhage, rheumatoid arthritis, tremors, increased perspiration, systemic lupus erythematosus, blurred vision, gynecomastia, thrombocytopenic purpura.
Read the entire FDA prescribing information for Atromid-S (Clofibrate) »
Additional Atromid-S Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.